Latest Alphabet Inc. Stock Portfolio
Alphabet Inc. Performance:
2025 Q3: 11.51%YTD: 28.72%2024: -3.93%
Performance for 2025 Q3 is 11.51%, and YTD is 28.72%, and 2024 is -3.93%.
About Alphabet Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Alphabet Inc. reported an equity portfolio of $2.4 Billions as of 30 Sep, 2025.
The top stock holdings of Alphabet Inc. are ASTS, PL, . The fund has invested 18.2% of it's portfolio in AST SPACEMOBILE INC and 17.2% of portfolio in PLANET LABS PBC.
The fund managers got completely rid off VERVE THERAPEUTICS INC (VERV) stocks. They significantly reduced their stock positions in METSERA INC. Alphabet Inc. opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUT. The fund showed a lot of confidence in some stocks as they added substantially to PRIME MEDICINE INC.
The top stock holdings of Alphabet Inc. are ASTS, PL, . The fund has invested 18.2% of it's portfolio in AST SPACEMOBILE INC and 17.2% of portfolio in PLANET LABS PBC.
The fund managers got completely rid off VERVE THERAPEUTICS INC (VERV) stocks. They significantly reduced their stock positions in METSERA INC. Alphabet Inc. opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUT. The fund showed a lot of confidence in some stocks as they added substantially to PRIME MEDICINE INC.
Alphabet Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Alphabet Inc. made a return of 11.51% in the last quarter. In trailing 12 months, it's portfolio return was 42.19%.
New Buys
| Ticker | $ Bought |
|---|---|
| bridgebio oncology therapeut | 32,691,800 |
| figma inc | 11,182,200 |
New stocks bought by Alphabet Inc.
Additions
| Ticker | % Inc. |
|---|---|
| prime medicine inc | 9.96 |
Additions to existing portfolio by Alphabet Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| metsera inc | -23.75 |
Alphabet Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| verve therapeutics inc | -136,652,000 |
Alphabet Inc. got rid off the above stocks
Sector Distribution
Alphabet Inc. has about 35.2% of it's holdings in Technology sector.
| Sector | % |
|---|---|
| Technology | 35.2 |
| Others | 33.5 |
| Industrials | 17.2 |
| Healthcare | 14 |
Market Cap. Distribution
Alphabet Inc. has about 2.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 36.7 |
| UNALLOCATED | 33.6 |
| MID-CAP | 25.9 |
| LARGE-CAP | 2.9 |
Stocks belong to which Index?
About 56.9% of the stocks held by Alphabet Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54 |
| Others | 43.1 |
| S&P 500 | 2.9 |
Alphabet Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Alphabet Inc.
Alphabet Inc. has 37 stocks in it's portfolio. About 89.1% of the portfolio is in top 10 stocks. FRSH proved to be the most loss making stock for the portfolio. PL was the most profitable stock for Alphabet Inc. last quarter.
Last Reported on: 07 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.02 | 175,866 | 520,563 | unchanged | 0.00 | ||
| ASTS | ast spacemobile inc | 18.22 | 8,943,490 | 438,946,000 | unchanged | 0.00 | ||
| AUTL | autolus therapeutics plc | 0.05 | 698,262 | 1,138,170 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 0.32 | 321,604 | 7,805,330 | unchanged | 0.00 | ||
| DXCM | dexcom inc | 2.90 | 1,036,940 | 69,775,500 | unchanged | 0.00 | ||
| EXAS | exact sciences corp | 0.05 | 23,205 | 1,269,550 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 0.10 | 500,901 | 2,449,410 | unchanged | 0.00 | ||
| FRSH | freshworks inc | 7.92 | 16,206,600 | 190,752,000 | unchanged | 0.00 | ||
| FULC | fulcrum therapeutics inc | 0.00 | 14,262 | 131,210 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc | 0.45 | 1,464,020 | 10,848,400 | unchanged | 0.00 | ||
| GTLB | gitlab inc | 5.10 | 2,724,710 | 122,830,000 | unchanged | 0.00 | ||
| HYPR | hyperfine inc | 0.05 | 898,720 | 1,303,140 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc | 0.20 | 293,256 | 4,762,480 | unchanged | 0.00 | ||
| OSCR | oscar health inc | 0.38 | 481,988 | 9,124,030 | unchanged | 0.00 | ||
| PATH | uipath inc | 3.91 | 7,034,340 | 94,119,400 | unchanged | 0.00 | ||
| PL | planet labs pbc | 17.21 | 31,942,600 | 414,615,000 | unchanged | 0.00 | ||
| QNCX | quince therapeutics inc | 0.01 | 189,122 | 308,269 | unchanged | 0.00 | ||
| RGEN | repligen corp | 0.00 | 383 | 51,196 | unchanged | 0.00 | ||
| RLAY | relay therapeutics inc | 0.34 | 1,568,750 | 8,188,890 | unchanged | 0.00 | ||
| RVMD | revolution medicines inc | 8.01 | 4,133,280 | 193,024,000 | unchanged | 0.00 | ||